Orgaran (Danaparoid Sodium)

Danaparoid Sodium, the active ingredient in Orgaran, is an anticoagulant presented as a sterile solution for parenteral use. It is used to prevent and treat clotting disorders in patients requiring anticoagulation therapy, particularly during procedures.

GNH USA supplies Orgaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and transplant centres worldwide.

Orgaran is employed across several clinical scenarios that involve abnormal hemostasis or thrombotic risk. - Heparin‑induced thrombocytopenia (HIT): Provides anticoagulation when the standard heparin therapy is contra‑indicated. - Cardiovascular surgery or cardioprevention procedures such by the . . -  . - . -